218 related articles for article (PubMed ID: 33759681)
1. Hematological manifestations and complications of Gaucher disease.
Revel-Vilk S; Szer J; Zimran A
Expert Rev Hematol; 2021 Apr; 14(4):347-354. PubMed ID: 33759681
[No Abstract] [Full Text] [Related]
2. Gaucher Disease for Hematologists.
Özdemir GN; Gündüz E
Turk J Haematol; 2022 Jun; 39(2):136-139. PubMed ID: 35439918
[TBL] [Abstract][Full Text] [Related]
3. A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact.
Zimran A; Ruchlemer R; Revel-Vilk S
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):389-394. PubMed ID: 33275748
[TBL] [Abstract][Full Text] [Related]
4. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
Kaplan P; Andersson HC; Kacena KA; Yee JD
Arch Pediatr Adolesc Med; 2006 Jun; 160(6):603-8. PubMed ID: 16754822
[TBL] [Abstract][Full Text] [Related]
5. The clinical course of untreated Gaucher disease in 22 patients over 10 years: hematological and skeletal manifestations.
Piran S; Roberts A; Patterson MA; Amato D
Blood Cells Mol Dis; 2009; 43(3):289-93. PubMed ID: 19793665
[TBL] [Abstract][Full Text] [Related]
6. Hematological manifestations and complications of Gaucher disease.
Linari S; Castaman G
Expert Rev Hematol; 2016 Jan; 9(1):51-8. PubMed ID: 26565753
[TBL] [Abstract][Full Text] [Related]
7. Gaucher disease: A cause of massive splenomegaly in a 15-year-old black African male.
Ramdin T; Schapkaitz E; Varughese S; Sevitz H
S Afr Med J; 2022 Feb; 112(1):13515. PubMed ID: 35139999
[TBL] [Abstract][Full Text] [Related]
8. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.
Mistry PK; Sadan S; Yang R; Yee J; Yang M
Am J Hematol; 2007 Aug; 82(8):697-701. PubMed ID: 17492645
[TBL] [Abstract][Full Text] [Related]
9. GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia.
Pession A; Di Rocco M; Venturelli F; Tappino B; Morello W; Santoro N; Giordano P; Filippini B; Rinieri S; Russo G; Girardi K; Ruggiero A; Galea E; Antonucci R; Tovaglieri N; Porta F; Tartaglione I; Giona F; Fagioli F; Burlina A;
Orphanet J Rare Dis; 2023 Jun; 18(1):151. PubMed ID: 37328863
[TBL] [Abstract][Full Text] [Related]
10. Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance.
Giuffrida G; Markovic U; Condorelli A; Duminuco A; Calafiore V; Conticello C; Romano A; Grasso S; Riccobene C; Ragusa MTV; Esposito B; Nicolosi D; Calagna M; Nardo A; Consoli U; Uccello G; Di Giacomo V; Neri S; Cingari MR; Rodà F; Innao V; Fiumara A; Duro G; Zizzo C; Di Raimondo F
Eur J Haematol; 2023 Dec; 111(6):922-929. PubMed ID: 37747757
[TBL] [Abstract][Full Text] [Related]
11. Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients.
Neudorfer O; Hadas-Halpern I; Elstein D; Abrahamov A; Zimran A
Am J Hematol; 1997 May; 55(1):28-34. PubMed ID: 9136914
[TBL] [Abstract][Full Text] [Related]
12. Assessing the diagnostic utility of the Gaucher Earlier Diagnosis Consensus (GED-C) scoring system using real-world data.
Revel-Vilk S; Shalev V; Gill A; Paltiel O; Manor O; Tenenbaum A; Azani L; Chodick G
Orphanet J Rare Dis; 2024 Feb; 19(1):71. PubMed ID: 38365689
[TBL] [Abstract][Full Text] [Related]
13. Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant data.
Raskovalova T; Deegan PB; Yang R; Pavlova E; Stirnemann J; Labarère J; Zimran A; Mistry PK; Berger M
Syst Rev; 2017 Apr; 6(1):87. PubMed ID: 28427477
[TBL] [Abstract][Full Text] [Related]
14. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.
Mehta A; Kuter DJ; Salek SS; Belmatoug N; Bembi B; Bright J; Vom Dahl S; Deodato F; Di Rocco M; Göker-Alpan O; Hughes DA; Lukina EA; Machaczka M; Mengel E; Nagral A; Nakamura K; Narita A; Oliveri B; Pastores G; Pérez-López J; Ramaswami U; Schwartz IV; Szer J; Weinreb NJ; Zimran A
Intern Med J; 2019 May; 49(5):578-591. PubMed ID: 30414226
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
Nguyen Y; Stirnemann J; Lautredoux F; Cador B; Bengherbia M; Yousfi K; Hamroun D; Astudillo L; Billette de Villemeur T; Brassier A; Camou F; Dalbies F; Dobbelaere D; Gaches F; Leguy-Seguin V; Masseau A; Pers YM; Pichard S; Serratrice C; Berger MG; Fantin B; Belmatoug N; On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069933
[TBL] [Abstract][Full Text] [Related]
16. Gaucher's disease: a paradigm for interventional genetics.
Germain DP
Clin Genet; 2004 Feb; 65(2):77-86. PubMed ID: 14984463
[TBL] [Abstract][Full Text] [Related]
17. [Gaucher disease: A review].
Nguyen Y; Stirnemann J; Belmatoug N
Rev Med Interne; 2019 May; 40(5):313-322. PubMed ID: 30638965
[TBL] [Abstract][Full Text] [Related]
18. Gaucher disease: haematological presentations and complications.
Thomas AS; Mehta A; Hughes DA
Br J Haematol; 2014 May; 165(4):427-40. PubMed ID: 24588457
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of different bone marrow examination methods in the diagnosis of adults with sporadic Gaucher disease type 1.
Machaczka M; Markuszewska-Kuczyńska A; Regenthal S; Jurczyszyn A; Gałązka K; Wahlin BE; Klimkowska M
Pol Arch Med Wewn; 2014; 124(11):587-92. PubMed ID: 25188399
[TBL] [Abstract][Full Text] [Related]
20. Synchronous multiple myeloma and Gaucher disease.
Monge J; Chadburn A; Gergis U
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):42-45. PubMed ID: 31622574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
